58°
Baton Rouge, Louisiana
7 Day Forecast

Latest Weather Blog

Follow our weather team on social media

FDA approves new melanoma drug from Bristol-Myers

1 year 11 months 1 week ago December 22, 2014 Dec 22, 2014 Monday, December 22 2014 December 22, 2014 2:31 PM in Health
Source: Associated Press
By: APNewsNow

WASHINGTON - The Food and Drug Administration has approved a new drug from Bristol-Myers Squibb to treat the deadliest form of skin cancer.

The agency approved Opdivo for patients with hard-to-treat melanoma that cannot be removed through surgery or has spread throughout the body. The approval was based on preliminary studies showing the drug helped shrink tumors in some patients.

About 76,100 people in the U.S. will be diagnosed with melanoma this year and 9,710 people are expected to die from the disease.

Melanoma long has been considered one of the toughest cancers to treat, with few drug options up until a few years ago. Since 2011, the FDA has approved seven new drugs for the skin cancer, including Opdivo.

More News

Desktop News

Click to open Continuous News in a sidebar that updates in real-time.
Radar
7 Days